| Online-Ressource |
Verfasst von: | Vierthaler, Marlene [VerfasserIn]  |
| Sun, Qian [VerfasserIn]  |
| Wang, Yiman [VerfasserIn]  |
| Steinfass, Tamara [VerfasserIn]  |
| Poelchen, Juliane [VerfasserIn]  |
| Hielscher, Thomas [VerfasserIn]  |
| Novak, Daniel [VerfasserIn]  |
| Umansky, Viktor [VerfasserIn]  |
| Utikal, Jochen [VerfasserIn]  |
Titel: | ADCK2 knockdown affects the migration of melanoma cells via MYL6 |
Verf.angabe: | Marlene Vierthaler, Qian Sun, Yiman Wang, Tamara Steinfass, Juliane Poelchen, Thomas Hielscher, Daniel Novak, Viktor Umansky, Jochen Utikal |
E-Jahr: | 2022 |
Jahr: | 20 February 2022 |
Umfang: | 18 S. |
Fussnoten: | This article belongs to the Special Issue Epidemiology and Biological Features of Melanoma ; Gesehen am 09.06.2022 |
Titel Quelle: | Enthalten in: Cancers |
Ort Quelle: | Basel : MDPI, 2009 |
Jahr Quelle: | 2022 |
Band/Heft Quelle: | 14(2022), 4, Artikel-ID 1071, Seite 1-18 |
ISSN Quelle: | 2072-6694 |
Abstract: | Background: ADCK2 is a member of the AarF domain-containing kinase family, which consists of five members, and has been shown to play a role in CoQ metabolism. However, ADCKs have also been connected to cancer cell survival, proliferation and motility. In this study, we investigated the role of ADCK2 in melanoma. Methods: The effect of ADCK2 on melanoma cell motility was evaluated by a scratch assay and a transwell invasion assay upon siRNA-mediated knockdown or stable overexpression of ADCK2. Results: We found that high levels of intratumoral ADCK2 and MYL6 are associated with a higher survival rate in melanoma patients. Knocking down ADCK2 resulted in enhanced cell migration of melanoma cells. Moreover, ADCK2-knockdown cells adopted a more dedifferentiated phenotype. A gene expression array revealed that the expression of ADCK2 correlated with the expressions of MYL6 and RAB2A. Knocking down MYL6 in ADCK2-overexpressing cells could abrogate the effect of ADCK2 overexpression and thus confirm the functional connection between ADCK2 and MYL6. Conclusion: ADCK2 affects melanoma cell motility, most probably via MYL6. Our results allow the conclusion that ADCK2 could act as a tumor suppressor in melanoma. |
DOI: | doi:10.3390/cancers14041071 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.3390/cancers14041071 |
| kostenfrei: Volltext: https://www.mdpi.com/2072-6694/14/4/1071 |
| DOI: https://doi.org/10.3390/cancers14041071 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | ADCK2 |
| cancer |
| melanoma |
| motility |
| MYL6 |
K10plus-PPN: | 1806534398 |
Verknüpfungen: | → Zeitschrift |
ADCK2 knockdown affects the migration of melanoma cells via MYL6 / Vierthaler, Marlene [VerfasserIn]; 20 February 2022 (Online-Ressource)